BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20308304)

  • 1. Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies.
    Tilahun ME; Rajagopalan G; Shah-Mahoney N; Lawlor RG; Tilahun AY; Xie C; Natarajan K; Margulies DH; Ratner DI; Osborne BA; Goldsby RA
    Infect Immun; 2010 Jun; 78(6):2801-11. PubMed ID: 20308304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.
    Tilahun ME; Kwan A; Natarajan K; Quinn M; Tilahun AY; Xie C; Margulies DH; Osborne BA; Goldsby RA; Rajagopalan G
    PLoS One; 2011; 6(11):e27203. PubMed ID: 22102880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
    Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G
    Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.
    Dutta K; Varshney AK; Franklin MC; Goger M; Wang X; Fries BC
    J Biol Chem; 2015 Mar; 290(11):6715-30. PubMed ID: 25572397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel protective human monoclonal antibody, LXY8, that targets the key neutralizing epitopes of staphylococcal enterotoxin B.
    Hu N; Qiao C; Wang J; Wang Z; Li X; Zhou L; Wu J; Zhang D; Feng J; Shen B; Zhang J; Luo L
    Biochem Biophys Res Commun; 2021 Apr; 549():120-127. PubMed ID: 33667709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.
    Varshney AK; Wang X; Aguilar JL; Scharff MD; Fries BC
    mBio; 2014 Jun; 5(3):e01007-14. PubMed ID: 24917594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock.
    Varshney AK; Wang X; Cook E; Dutta K; Scharff MD; Goger MJ; Fries BC
    J Biol Chem; 2011 Mar; 286(11):9737-47. PubMed ID: 21233204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterisation of monoclonal antibodies specific for staphylococcal enterotoxin B.
    Lin YS; Largen MT; Newcomb JR; Rogers TJ
    J Med Microbiol; 1988 Dec; 27(4):263-70. PubMed ID: 3199425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine monoclonal antibodies against staphylococcal enterotoxin B: production and characterization.
    Goyache J; Orden JA; Blanco JL; Hernández J; Doménech A; Suárez G; Gómez-Lucía E
    FEMS Microbiol Immunol; 1992 Jul; 4(5):247-54. PubMed ID: 1515153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.
    Hamad AR; Herman A; Marrack P; Kappler JW
    J Exp Med; 1994 Aug; 180(2):615-21. PubMed ID: 7519243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the neutralization and specificity of Staphylococcal enterotoxin B against its MHC Class II binding site.
    Xia T; Liang S; Wang H; Hu S; Sun Y; Yu X; Han J; Li J; Guo S; Dai J; Lou Z; Guo Y
    MAbs; 2014; 6(1):119-29. PubMed ID: 24423621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.
    Liu Y; Song Z; Ge S; Zhang J; Xu L; Yang F; Lu D; Luo P; Gu J; Zou Q; Zeng H
    Hum Vaccin Immunother; 2020 Jul; 16(7):1708-1718. PubMed ID: 32275466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome.
    Karauzum H; Chen G; Abaandou L; Mahmoudieh M; Boroun AR; Shulenin S; Devi VS; Stavale E; Warfield KL; Zeitlin L; Roy CJ; Sidhu SS; Aman MJ
    J Biol Chem; 2012 Jul; 287(30):25203-15. PubMed ID: 22645125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.
    Pang LT; Kum WW; Chow AW
    Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B.
    Goldbach-Mansky R; King PD; Taylor AP; Dupont B
    Int Immunol; 1992 Dec; 4(12):1351-60. PubMed ID: 1363054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression.
    Busbee PB; Nagarkatti M; Nagarkatti PS
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):7-16. PubMed ID: 24200994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.
    Larkin EA; Stiles BG; Ulrich RG
    PLoS One; 2010 Oct; 5(10):e13253. PubMed ID: 20949003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a recombinant double mutant of staphylococcal enterotoxin B (SEB-H32Q/K173E) with enhanced antitumor activity effects and decreased pyrexia.
    Gu L; Yue J; Zheng Y; Zheng X; Wang J; Wang Y; Li J; Jiang Y; Jiang H
    PLoS One; 2013; 8(2):e55892. PubMed ID: 23405232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superantigen and endotoxin synergize in the induction of lethal shock.
    Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
    Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.
    Woody MA; Krakauer T; Ulrich RG; Stiles BG
    J Infect Dis; 1998 Apr; 177(4):1013-22. PubMed ID: 9534976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.